Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-11 @ 10:29 PM
Study NCT ID:
NCT00038168
Status:
COMPLETED
Last Update Posted:
2012-08-01
First Post:
2002-05-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: